US conditionally clears Integra/Codman Neuro after UK waves through

Sonya Lalli

28 September 2017

Integra LifeSciences has agreed to divest a range of healthcare product lines to nab US clearance for its acquisition of Johnson & Johnson’s neurosurgery medical products business – a deal already unconditionally cleared in the UK on the de minimis exception.

Subscribe to Global Competition Review

Subscribe to unlock unlimited access

Get news, unique commentary, expert analysis and essential resources from the Global Competition Review experts.

Subscribe now

Already have access? Login below

Sonya Lalli

View full biography

Author

[email protected]

Tipline

Midnight blues: The Tipline for 1 February 2023
Many of us spent yesterday waiting for news from the US District Court for the Northern District of California as it eventually drip-fed last-minute updates on Meta/Within. First, the Federal Trade Commission filed a last-ditch request to stop the companies closing their deal today as planned, given Judge Edward Davila’s ruling on the challenge was nowhere in sight. Then, just before midnight, two sealed orders appeared – one on the merger challenge, the other …
Fingers crossed: The Tipline for 31 January 2023
Safeties for safety: The Tipline for 30 January 2023

US conditionally clears Integra/Codman Neuro after UK waves through

Subscribe to Global Competition Review

Subscribe to unlock unlimited access

Already have access? Login below

Related Topics

Sonya Lalli